FDA Approves Expanded Use of GSK Hib Vaccine From Booster Dose To Full Series
Philadelphia, 15 January 2016 -- GSK [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration approved an expanded age indication for Hiberix [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)]. Hiberix is now indicated...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news
More News: ActHIB | Drugs & Pharmacology | Food and Drug Administration (FDA) | HIB Vaccine | Tetanus | Tetanus Vaccine | Vaccines